封面
市场调查报告书
商品编码
1741265

沙门氏菌检测市场:依检测方法、依样本种类、依应用、依最终使用者、按地区

Salmonella Testing Market, By Testing Method, By Sample Type, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3个工作天内

价格
简介目录

沙门氏菌检测市场规模预计在 2025 年为 36.4 亿美元,预计到 2032 年将达到 61.6 亿美元,2025 年至 2032 年的年复合成长率(CAGR)为 7.8%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 36.4亿美元
效能数据 2020-2024 预测期 2025-2032
预测期:2025-2032年复合年增长率: 7.80% 2032年价值预测 61.6亿美元

沙门氏菌属是一类会导致人类全身性疾病(非伤寒沙门氏菌病)的细菌,也是全球食源性疾病的主要原因之一。沙门氏菌具有复杂的生理机能,能够利用多种营养来源,并在各种环境中生存。沙门氏菌也能够利用复杂的毒力机制适应环境压力并克服免疫反应。

市场动态

沙门氏菌引起的食源性疾病是全球食物中毒的常见原因。沙门氏菌疫情的增加引发了公众对健康的担忧,推动了对沙门氏菌检测的需求。快速且准确的检测对于识别受污染食品、启动必要的召回以及进一步阻止疾病传播至关重要。

对于食品公司来说,实施沙门氏菌检测通讯协定和维护检测设施的成本非常高昂,尤其对于中小型企业 (SME) 而言。试剂、检测用品和合格人员的前期成本可能很高。维护和更新检测系统以及遵守法规相关的持续成本可能会限制全面实施沙门氏菌检测计画。

本研究的主要特点

  • 本报告对全球沙门氏菌检测市场进行了详细分析,并提供了市场规模和预测期年复合成长率(CAGR%)(假设 2024 年为基准年)。
  • 它还强调了各个领域的潜在收益成长机会,并说明了该市场的引人注目的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
  • 它根据公司亮点、产品系列、关键亮点、财务表现和策略等参数,概述了全球沙门氏菌检测市场的主要企业。
  • 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 全球沙门氏菌检测市场报告迎合了该行业的各个相关人员,例如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
  • 相关人员将透过用于分析全球沙门氏菌检测市场的各种策略矩阵来做出决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章市场动态、法规与趋势分析

  • 市场动态
    • 驱动程式
  • 沙门氏菌感染疾病发生率增加
    • 限制因素
  • 沙门氏菌检测高成本
    • 机会
  • 拓展新兴市场
  • 影响分析
  • 主要亮点
  • 监管情景
  • 产品发布/核准
  • PEST分析
  • 波特分析
  • 併购场景

4. 沙门氏菌检测市场-冠状病毒(COVID-19)大流行的影响

  • COVID-19流行病学
  • 供需侧分析
  • 经济影响

5. 沙门氏菌检测市场(依检测方法划分),2020 年至 2032 年

  • 基于文化
  • 分子基础
  • 免疫检测

6. 2020 年至 2032 年沙门氏菌检测市场(依样本类型)

  • 食物
  • 环境表面

7. 沙门氏菌检测市场(按应用划分),2020 年至 2032 年

  • 临床诊断
  • 食品安全检测
  • 兽医诊断

8. 沙门氏菌检测市场(以最终用户划分),2020 年至 2032 年

  • 食品生产商和製造商
  • 合约检验机构
  • 政府和监管机构

9. 沙门氏菌检测市场(按地区划分),2020 年至 2032 年

  • 北美洲
      • 美国
      • 加拿大
  • 欧洲
      • 英国
      • 德国
      • 义大利
      • 法国
      • 西班牙
      • 俄罗斯
      • 其他欧洲国家
  • 亚太地区
      • 中国
      • 印度
      • 日本
      • 澳洲
      • 韩国
      • ASEAN
      • 其他亚太地区
  • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
      • 其他拉丁美洲
  • 中东
      • 海湾合作委员会国家
      • 以色列
      • 其他中东地区
  • 非洲
      • 北非
      • 南非
      • 中部非洲

第十章 竞争格局

  • Thermo Fisher Scientific
  • Vitrosens Biotechnology
  • Merck KGaA
  • bioMerieux SA
  • Neogen Corporation
  • QIAGEN NV
  • 3M
  • PerkinElmer Inc.
  • Romer Labs Division Holding GmbH
  • Eurofins Scientific
  • Hardy Diagnostics
  • Charles River Laboratories
  • LabCorp
  • R-Biopharm AG
  • Biomerica, Inc.

第 11 章 章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI6013

Salmonella Testing Market is estimated to be valued at USD 3.64 Bn in 2025 and is expected to reach USD 6.16 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.8% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 3.64 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 7.80% 2032 Value Projection: USD 6.16 Bn

The genus Salmonella is a group of bacteria that causes human systemic disease (non-typhoid salmonellosis), and they are one of the leading causes of foodborne illness in the world. They are able to survive in different environments because of their complex physiology that allows them to use various nutrient sources. Salmonella is also able to adapt to environmental stresses and can overcome immune responses by using sophisticated virulence mechanisms.

Market Dynamics

All around the world, foodborne diseases are frequently caused by salmonella. The demand for Salmonella testing is being driven by the increase in Salmonella outbreaks, which is causing public health concerns. In order to identify contaminated food products, launch necessary recalls, and stop the spread of illnesses further, quick and precise testing is essential.

It can be expensive for food companies to implement testing protocols for salmonella and to maintain testing facilities, especially for small and medium-sized businesses (SMEs). Initial costs for reagents, testing tools, and qualified employees might be high. The implementation of thorough Salmonella testing programs can be constrained by the continuing costs related to maintaining and updating testing systems and complying with regulatory regulations.

Key Features of the Study:

  • This report provides an in-depth analysis of the global salmonella testing market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global salmonella testing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Thermo Fisher Scientific, Vitrosens Biotechnology, Merck KGaA, bioMerieux SA, Neogen Corporation, QIAGEN N.V., 3M, PerkinElmer Inc., Romer Labs Division Holding GmbH, Eurofins Scientific, Hardy Diagnostics, Charles River Laboratories, LabCorp, R-Biopharm AG, and Biomerica Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global salmonella testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global salmonella testing market

Detailed Segmentation:

  • By Testing Method:
    • Culture-based Methods
    • Molecular-based Methods
    • Immunoassays
  • By Sample Type:
    • Food
    • Water
    • Environmental Surfaces
  • By Application:
    • Clinical Diagnostics
    • Food Safety Testing
    • Veterinary Diagnostics
  • By End User:
    • Food Producers and Manufacturers
    • Contract Testing Laboratories
    • Government and Regulatory Bodies
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles
    • Thermo Fisher Scientific
    • Vitrosens Biotechnology
    • Merck KGaA
    • bioMerieux SA
    • Neogen Corporation
    • QIAGEN N.V.
    • 3M
    • PerkinElmer Inc.
    • Romer Labs Division Holding GmbH
    • Eurofins Scientific
    • Hardy Diagnostics
    • Charles River Laboratories
    • LabCorp
    • R-Biopharm AG
    • Biomerica, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Salmonella Testing, By Testing Method
    • Market Salmonella Testing, By Sample Type
    • Market Salmonella Testing, By Application
    • Market Salmonella Testing, By End User
    • Market Salmonella Testing, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Increasing Incidence of Salmonella Outbreaks
    • Restraints
  • High Costs of Salmonella Testing
    • Opportunities
  • Expansion in Emerging Markets
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Salmonella Testing Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Salmonella Testing Market, By Testing Method, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Culture-based Methods
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Molecular-based Methods
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Immunoassays
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Salmonella Testing Market, By Sample Type, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Food
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Water
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Environmental Surfaces
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Salmonella Testing Market, By Application, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Clinical Diagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Food Safety Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Veterinary Diagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Salmonella Testing Market, By End User, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Food Producers and Manufacturers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Contract Testing Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Government and Regulatory Bodies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

9. Salmonella Testing Market, By Region, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2021 - 2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Testing Method, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sample Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Testing Method, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sample Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Testing Method, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sample Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Testing Method, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sample Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Testing Method, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sample Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Testing Method, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sample Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
      • North Africa
      • South Africa
      • Central Africa

10. Competitive Landscape

  • Thermo Fisher Scientific
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Vitrosens Biotechnology
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Merck KGaA
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • bioMerieux SA
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Neogen Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • QIAGEN N.V.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • 3M
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • PerkinElmer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Romer Labs Division Holding GmbH
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Eurofins Scientific
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Hardy Diagnostics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Charles River Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • LabCorp
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • R-Biopharm AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Biomerica, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

11. Section

  • Research Methodology
  • About us